138 related articles for article (PubMed ID: 34814695)
1. Bone invasion by oral squamous cell carcinoma.
Král D; Pink R; Šašková L; Michálek J; Tvrdý P
Acta Chir Plast; 2021; 63(3):139-144. PubMed ID: 34814695
[TBL] [Abstract][Full Text] [Related]
2. The RANKL/RANK system as a therapeutic target for bone invasion by oral squamous cell carcinoma (Review).
Jimi E; Shin M; Furuta H; Tada Y; Kusukawa J
Int J Oncol; 2013 Mar; 42(3):803-9. PubMed ID: 23354319
[TBL] [Abstract][Full Text] [Related]
3. The cellular and molecular mechanisms of bone invasion by oral squamous cell carcinoma.
Jimi E; Furuta H; Matsuo K; Tominaga K; Takahashi T; Nakanishi O
Oral Dis; 2011 Jul; 17(5):462-8. PubMed ID: 21496184
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and predictive markers for perineural and bone invasion of oral squamous cell carcinoma.
Michalek J; Brychtova S; Pink R; Dvorak Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Dec; 163(4):302-308. PubMed ID: 31435075
[TBL] [Abstract][Full Text] [Related]
6. Bone invasion by oral squamous cell carcinoma: Molecular alterations leading to osteoclastogenesis - a review of literature.
Vaassen LAA; Speel EM; Kessler PAWH
J Craniomaxillofac Surg; 2017 Sep; 45(9):1464-1471. PubMed ID: 28756966
[TBL] [Abstract][Full Text] [Related]
7. Oral squamous cell carcinoma cells induce osteoclast differentiation by suppression of osteoprotegerin expression in osteoblasts.
Tada T; Jimi E; Okamoto M; Ozeki S; Okabe K
Int J Cancer; 2005 Aug; 116(2):253-62. PubMed ID: 15800904
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of cortical mandibular bone in patients with oral squamous cell carcinoma.
Rabelo GD; Coutinho-Camillo C; Kowalski LP; Portero-Muzy N; Roux JP; Chavassieux P; Alves FA
Clin Oral Investig; 2018 Mar; 22(2):783-790. PubMed ID: 28647863
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of RANKL, RANK, and OPG in human oral squamous cell carcinoma.
Chuang FH; Hsue SS; Wu CW; Chen YK
J Oral Pathol Med; 2009 Nov; 38(10):753-8. PubMed ID: 19566744
[TBL] [Abstract][Full Text] [Related]
10. Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
Cui N; Nomura T; Noma H; Yokoo K; Takagi R; Hashimoto S; Okamoto M; Sato M; Yu G; Guo C; Shibahala T
Clin Cancer Res; 2005 Apr; 11(7):2713-9. PubMed ID: 15814653
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of osteoprotegerin expression correlates with bone invasion and predicts poor clinical outcome in oral cancer.
Russmueller G; Moser D; Würger T; Wrba F; Christopoulos P; Kostakis G; Seemann R; Stadler V; Wimmer G; Kornek G; Psyrri A; Filipits M; Perisanidis C
Oral Oncol; 2015 Mar; 51(3):247-53. PubMed ID: 25532817
[TBL] [Abstract][Full Text] [Related]
13. Oral squamous cell carcinoma cells modulate osteoclast function by RANKL-dependent and -independent mechanisms.
Tada T; Shin M; Fukushima H; Okabe K; Ozeki S; Okamoto M; Jimi E
Cancer Lett; 2009 Feb; 274(1):126-31. PubMed ID: 18930344
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effect of temsirolimus against oral squamous cell carcinoma associated with bone destruction.
Okui T; Shimo T; Fukazawa T; Kurio N; Hassan NM; Honami T; Takaoka M; Naomoto Y; Sasaki A
Mol Cancer Ther; 2010 Nov; 9(11):2960-9. PubMed ID: 20858724
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts promote bone invasion in oral squamous cell carcinoma.
Elmusrati AA; Pilborough AE; Khurram SA; Lambert DW
Br J Cancer; 2017 Sep; 117(6):867-875. PubMed ID: 28742795
[TBL] [Abstract][Full Text] [Related]
16. A new osteoclastogenesis pathway induced by cancer cells targeting osteoclast precursor cells.
Wada A; Tsuchiya M; Ozaki-Honda Y; Kayamori K; Sakamoto K; Yamaguchi A; Ikeda T
Biochem Biophys Res Commun; 2019 Jan; 509(1):108-113. PubMed ID: 30578079
[TBL] [Abstract][Full Text] [Related]
17. [Osteoclastic bone destruction and its regulating factors in oral squamous cell carcinoma].
Cui NH; Zhang W; Wang EB; Wei MJ; Guo CB; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 39(1):30-2. PubMed ID: 17304322
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of NF-κB suppresses bone invasion by oral squamous cell carcinoma in vivo.
Furuta H; Osawa K; Shin M; Ishikawa A; Matsuo K; Khan M; Aoki K; Ohya K; Okamoto M; Tominaga K; Takahashi T; Nakanishi O; Jimi E
Int J Cancer; 2012 Sep; 131(5):E625-35. PubMed ID: 22262470
[TBL] [Abstract][Full Text] [Related]
19. Histological pattern of mandibular invasion by oral squamous cell carcinoma.
Wong RJ; Keel SB; Glynn RJ; Varvares MA
Laryngoscope; 2000 Jan; 110(1):65-72. PubMed ID: 10646718
[TBL] [Abstract][Full Text] [Related]
20. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
